An announcement from Elanco Animal Health (ELAN) is now available.
Elanco Animal Health Incorporated has struck a cooperation agreement with Ancora Catalyst Institutional, leading to the appointment of Kathy V. Turner and Craig S. Wallace to its Board of Directors, effective March 29, 2024. Both appointees will also serve on the newly named Finance, Strategy and Oversight Committee. This move comes with certain commitments from the Ancora Parties, including standstill restrictions and voting commitments, enhancing the company’s governance framework. The expansion of the board from 12 to 14 members marks a strategic shift for Elanco, aligning with shareholder interests and setting the stage for future financial oversight.
Learn more about ELAN stock on TipRanks’ Stock Analysis page.
